Company profile: AMW
1.1 - Company Overview
Company description
- Provider of drug delivery systems, including active ingredient/biodegradable implants and transdermal passive and microchip-controlled patches for oncology, pain therapy, and neurology. Offers biodegradable Goserelin and Leuprorelin implants for hormone-dependent tumors, plus CDMO manufacturing, inhouse innovation, joint development, and regulatory affairs services.
Products and services
- Contract Development and Manufacturing Organization (CDMO): Delivers custom manufacturing services for biodegradable implant formulations with GMP-compliant production and rigorous quality control, ensuring compliant fabrication of implant-based drug delivery products
- Goserelin Implant: Biodegradable implant releasing synthetic peptide goserelin over one or three months, used primarily for treating hormone-dependent tumors such as prostate cancer
- Leuprorelin Implant: Biodegradable implant releasing synthetic peptide leuprorelin over three months, used primarily for treating hormone-dependent tumors such as prostate cancer
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AMW
Enzymatics
HQ: United States
Website
- Description: Provider of independent, ISO 13485:2003 certified OEM enzyme manufacturing, supplying enzymes for PCR (standard and hot-start Taq polymerases), reverse transcriptases, RNA polymerases and ligases, RNA digestion and protection (RNase A and RNase inhibitors), DNA ligation (T4 DNA Ligase), and gene synthesis (assembly of oligodeoxynucleotides).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enzymatics company profile →
Cryoniss
HQ: United Kingdom
Website
- Description: Provider of temperature-controlled biobanking and cold-chain logistics for life sciences, offering regulated storage of human biological samples at vapour phase liquid nitrogen, -80°C, -20°C, +4°C and ambient; cell banking and culture with next-day dispatch; bioreagents storage with cloud-based traceability; cell line QC testing via preferred suppliers; end-to-end sample transport; and access to samples for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoniss company profile →
Cevec
HQ: Germany
Website
- Description: Provider of biopharmaceutical production expertise using a unique human cell-based expression system, developing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. CAP-Go enables production of proteins beyond antibodies, including complex glycosylated proteins that are difficult to express in conventional cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cevec company profile →
Mablink Bioscience
HQ: France
Website
- Description: Provider of biotechnology focused on developing a new class of cancer drugs, Antibody Drug Conjugate (ADC).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mablink Bioscience company profile →
Xpand Biotech
HQ: The Netherlands
Website
- Description: Provider of bone repair and regeneration products based on proprietary surface science technology, with in-house R&D, manufacturing, and clean room facilities; based in Bilthoven, The Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpand Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AMW
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AMW
2.2 - Growth funds investing in similar companies to AMW
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AMW
4.2 - Public trading comparable groups for AMW
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →